Abstract:Mutated BRAF oncogene, which fuels unregulated MAPK pathway in most melanomas, can be targeted by a small-molecule drug vemurafenib. However, most of patients develop an acquired resistance during treatment or have an intrinsic resistance to this drug. Nonreceptor SRC tyrosine kinase is deregulated in most cancer cell types and can be efficiently inhibited by a small-molecule inhibitor dasatinib, an anticancer drug which is already used for the treatment of some cancers and is in final clinical trials for othe… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.